Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 16;25(1):10.
doi: 10.1007/s11882-024-01189-z.

Parosmia: Pathophysiology and Management

Affiliations
Review

Parosmia: Pathophysiology and Management

Xinni Xu et al. Curr Allergy Asthma Rep. .

Abstract

Purpose of review: Parosmia is a qualitative olfactory disorder in which there is a mismatch between the memory of an odor and the actual experience triggered by an odor. There has been a surge in parosmia-related publications since the COVID-19 pandemic. This review summarizes the latest clinical findings, theories on pathophysiology and potential treatment options.

Recent advances: Potential models of parosmia include peripheral or central hypotheses, which refer to aberrancies in olfactory neuron regeneration or information processing in central olfactory centers respectively. This leads to an incomplete or disorganized pattern of olfactory information relay. Studies using gas chromatography and functional magnetic resonance imaging have identified molecular triggers and intracranial functional connectivity patterns in parosmia respectively. Parosmia tends to occur in a delayed fashion after virus-induced anosmia. It may run a protracted course, but typically improves over time. Currently there are no generally approved, objective ways to ascertain the presence and measure the extent of parosmia. Evidence-based treatment for parosmia remains elusive. In some people, this can lead to health and quality of life issues.

Keywords: COVID-19; Dysosmia; Olfactory loss; Olfactory training; Parosmia; Qualitative olfactory dysfunction.

PubMed Disclaimer

Conflict of interest statement

Declarations. No funds, grants, or other support was received for this study. Since 2021, Thomas Hummel collaborates with the following companies: Sony, Tokyo, Japan; Smell and Taste Lab Geneva, Switzerland; Takasago, Paris, France; Cyrano, Delray Beach, FL, USA; Cynexo, Trieste, Italy; Sentosphere, Paris, France; NOAR, Sao Paulo, Brazil; Baia Foods, Madrid, Spain; Burghart, Holm, Germany. The remaining authors have no conflicts of interest to declare. Human and Animal Rights and Informed Consent: This article does not contain any studies with human or animal subjects performed by any of the authors. Competing Interests: The authors declare no competing interests.

References

    1. Hernandez AK, Landis BN, Altundag A, Fjaeldstad AW, Gane S, Holbrook EH, Huart C, Konstantinidis I, Lechner M, Macchi A, et al. Olfactory nomenclature: an orchestrated effort to clarify terms and definitions of Dysosmia, anosmia, Hyposmia, Normosmia, Hyperosmia, olfactory intolerance, Parosmia, and Phantosmia/olfactory hallucination. ORL J Otorhinolaryngol Relat Spec. 2023;85(6):312–20. https://doi.org/10.1159/000530211 . - DOI - PubMed
    1. Landis BN, Konnerth CG, Hummel T. A study on the frequency of olfactory dysfunction. Laryngoscope. 2004;114(10):1764–9. https://doi.org/10.1097/00005537-200410000-00017 . - DOI - PubMed
    1. Nordin S, Bramerson A, Millqvist E, Bende M. Prevalence of parosmia: the Skovde population-based studies. Rhinology. 2007;45(1):50–3. - PubMed
    1. Olofsson JK, Ekesten F, Nordin S. Olfactory distortions in the general population. Sci Rep. 2022;12(1):9776. https://doi.org/10.1038/s41598-022-13201-5 . - DOI - PubMed - PMC
    1. Nordin S, Murphy C, Davidson TM, Quinonez C, Jalowayski AA, Ellison DW. Prevalence and assessment of qualitative olfactory dysfunction in different age groups. Laryngoscope. 1996;106(6):739–44. https://doi.org/10.1097/00005537-199606000-00014 . - DOI - PubMed

LinkOut - more resources